InvestorsHub Logo
icon url

boston745

04/04/18 4:56 PM

#14815 RE: anon13333 #14813

It's not about the past, but the future:

On May 13, 2015, the Company entered into a joint agreement for research and development of silicon nitride-based devices. This agreement is effective for a period of five years from the date of commencement. The Company incurred payments of $0.03 million related to this agreement for each of the years ended December 31, 2017 and 2016.



Si3n4 can now be used in the following applications:

Such materials may be useful in, for example, manufacturing biomedical implants, such as intervertebral spacers or other spinal implants, orthopedic screws, plates, wires, or other fixation devices, articulation implants in the spine, hip, knee, shoulder, ankle or phalanges, catheters, implants for facial or other reconstructive plastic surgery, dental implants, and the like.



Hanson believe the products it'll launch this year will generate mid single digit growth. That's about 5+% a year on average starting 2019?

Second piece is, we’re going to launch these products, excellent product pipeline that I’ve talked about and we got to get to full launch as quickly as we can. I'm seeing that as being somewhere in the mid-2019 timeframe but that has to happen and we've got to do it effectively, right?
.....
I already said the pipeline is really full swing in mid-2019 and anyone who's done any kind of a culture change knows that it takes time. We're having immediate impact in this area. We're going to get quick results out of the gate, but to make it sustainable, it's just going to take time. It's a continuous improvement game. So when I just kind of put all those things together, I think realistically the way we should be thinking about this is a gradual recovery towards market growth if you will through 2019.

icon url

madg

04/04/18 5:40 PM

#14817 RE: anon13333 #14813

Actually it’s $1108.80 to $1.39 split adjusted since IPO.